About 30% to 40% of the world’s population is affected by some form of allergic disease, making allergy a routine consideration in primary care. But as interest in the microbiome grows, clinicians and patients face an important question: what does the evidence actually tell us about its role in allergic disease? This episode explores immune development, the hygiene and biodiversity hypotheses, food allergy, early-life tolerance, the gut-skin axis, atopic dermatitis, asthma, allergic rhinitis, antibiotic exposure, diagnostic testing, and early peanut introduction. The discussion separates established evidence from emerging associations and considers what, if anything, should change in clinical practice today. Clinicians will come away with practical guidance on maintaining evidence-based allergy diagnosis and management while understanding where microbiome research may shape future approaches to prevention and care.
Looking for allergy diagnostic codes from the labs you already use?
Time stamps
0:00 - Why Everyone Is Talking About the Microbiome
1:57 - Why Allergy Matters in Primary Care
3:01 - Genetics, Environment, and the Microbiome
7:03 - From Hygiene Hypothesis to Biodiversity
12:08 - The Microbiome and Food Allergy
14:01 - Butyrate, Metabolites, and Immune Regulation
16:49 - Food Allergy Diagnosis and Specific IgE
19:54 - Early Peanut Introduction and the LEAP Study
21:45 - Atopic Dermatitis and the Gut-Skin Axis
25:11 - Skin Care, Eczema, and Allergy Development
28:14 - Probiotics and Eczema Evidence
29:27 - Asthma, Allergic Rhinitis, and the Microbiome
32:18 - Respiratory Allergen Profiles and Specific IgE
34:20 - Antibiotics, Stewardship, and Allergy Risk
36:32 - Key Microbiome Takeaways for Clinicians
ImmunoCAST Voice (00:00):
ImmunoCAST is brought to you by Thermo Fisher Scientific, creators of ImmunoCAP Specific IgE diagnostics and Phadia Laboratory Systems.
Gary Falcetano (00:10):
I'm Gary Falcetano, a licensed and board certified PA with over 12 years experience in allergy and immunology.
Luke Lemons (00:16):
And I'm Luke Lemons with over six years experience writing for healthcare providers and educating on allergies. You're listening to Immunocast, your source for medically and scientifically backed allergy insights. It feels like everywhere we turn lately, somebody is talking about the microbiome. Patients are asking about probiotics, they're buying fermented food. Some are bringing commercial microbiome reports to the clinic asking for help interpreting them. And social media seems convinced that healing your gut is the answer to everything from eczema to anxiety or allergy.
Gary Falcetano (00:51):
It is literally everywhere you turn. So five years ago, I think most clinicians didn't have a single patient that asked about the microbiome. And now it's really become a part of routine conversations.
Luke Lemons (01:04):
And some parents are asking whether one course of antibiotics cause their child's food allergy. Others are wondering if they should start probiotic supplements during pregnancy. They're caring about their children's health, but the microbiome is really kind of taken on this mythical status as though it's the missing piece to everything.
Gary Falcetano (01:20):
Yeah. I think there's some really fascinating science here, but there is hype as well. And wherever there's kind of breakthroughs in science and medicine, we always have people kind of taking advantage of that as well and people seeing it as kind of a single source solution. So let's see what we can do. Let's see if we can break down some of the hype from the science.
Luke Lemons (01:40):
Yeah. So we'll talk about in this episode what we know about the microbiome, what we think we know, and most importantly, what should actually change in primary care when we think about food allergy related to the microbiome? Because if you're a busy clinician, that's really the question that matters.
Gary Falcetano (01:57):
Exactly. Why should a primary care provider even care? Allergies aren't becoming scarce or more rare. They're becoming incredibly common. Currently, about 30 to 40% of the world's population is affected by some type of allergic disease. So it really has become one of the most prevalent forms of chronic disease.
Luke Lemons (02:17):
Yeah. So one out of every three patients may have some form, whether that's allergic rhinitis, allergic asthma, atopic dermatitis, food allergy, or even a combination of those conditions. And so think about your clinic and maybe the schedule that you have tomorrow. Allergies are something that primary care deal with every single day.
Gary Falcetano (02:37):
Exactly. And we've talked about this before. We have definite peaks throughout the year. We see spring tree pollen season. We're coming up now on asthma peak week and kind of the back to school time when allergies and asthma really, really tend to peak because of that tsunami of triggers. It really is something we're encountering every day and we need to have really a better framework for how we address patients with allergy.
Luke Lemons (03:01):
But when we think about the microbiome, it's really a conversation of how do allergies develop? And so why don't we start there? And for decades, we've looked at primarily genetics and allergen exposure to explain how they develop. And genetics clearly matter. If mom and dad have allergic disease, the child's risk goes up, but genetics haven't changed dramatically over the past 50 years when it comes to the prevalence of allergic disease.
Gary Falcetano (03:27):
Exactly. So that really takes us more to epigenetics, how we express that genetic predisposition towards allergy and what kind of things we can do to really affect that expression of disease.
Luke Lemons (03:39):
Yeah. And so researchers start asking the question outside of genetics, what changed in the environment? And the answer is our understanding of the trillions of microorganisms living on and inside of us.
Gary Falcetano (03:54):
Exactly. We think of the environment as the trees, the air around us, but the major environment that we're in contact with every day and that's in contact with us is really our microbiome, both in our gut, in our lungs, on our skin.
Luke Lemons (04:08):
Yeah. We're carrying roughly as many microbial cells as human cells. And together these microbes contain far more genes than our own genome. We're kind of a transportation vessel or home for these microbial networks.
Gary Falcetano (04:23):
We used to think about this as kind of normal flora or pathogenic flora, and really thought about just how those potential infectious organisms could affect us. But it's really so much more than that. It's about how the microbiome interacts with us, how it educates the immune system, how it influences things like our epithelial barrier, and even the metabolites that it produced that communicates with the entire rest of our body, including our immune cells.
Luke Lemons (04:50):
And allergies truly are a disorder of immune regulation. So again, we begin asking, could these microbial communities help explain why some people develop allergic diseases and why others don't?
Gary Falcetano (05:02):
Exactly. Because that immune regulation is really immune dysregulation, right? And how does the microbiome play into that?
Luke Lemons (07:03):
It is the topic of the podcast. And so while that genetic sequencing was a huge breakthrough in our understanding of the microbial world, why don't we pair that with a big breakthrough or theory in the allergy world that is going to help us with this conversation around the microbiome and allergies?
Gary Falcetano (07:25):
We've mentioned this in previous episodes. Decades ago, the hygiene hypothesis really came into being, right? And that was a take on our immune systems and how becoming more clean, increasing use of antibiotics, increasing use of antiseptics on the skin, increasing use of antibiotics even in the food supply and becoming more sterile environments, not playing in the dirt, but being inside more. All of that combined to cause less of a challenge to our immune systems. And the hypothesis said if the immune system's bored, it's going to start doing things that normally it wouldn't do, like attacking typically innocuous substances like peanuts or pollens.
Luke Lemons (08:14):
When this was first suggested, the hygiene hypothesis, it made an intuitive sense. But over the past two decades, we've learned that this story is so much more nuanced. The message really, it's not that hygiene is bad. It's modern sanitation, vaccination, infection prevention have saved millions of life. Yeah, antibiotics alone. I mean, nobody's saying to abandon those advances over course. Instead, researchers now believe that the most important issue may be loss of exposure to diverse environmental microbes that have evolved alongside humans throughout the years. And those microbes may help educate the development of our immune system.
Gary Falcetano (08:57):
Exactly. So that's what is now kind of known as the biodiversity hypothesis or even the old friends hypothesis. Knowing that these microbes that have evolved with us for thousands of years really do have a beneficial impact, and it's a matter of just keeping things in balance.
Luke Lemons (12:08):
And so the microbiome appears to play a very important role in immune development, but how does that translate into actual allergic diseases we see every day? Because not allergic diseases have the same level of evidence on the impact of the microbiome.
Gary Falcetano (12:24):
Yeah. And I think the strongest story for the microbiome and how it affects us in general is really around food allergy. If we're talking about allergies, it's food allergy where I think it probably plays the biggest role.
Luke Lemons (12:39):
It's not about changing an adult's gut bacteria, but about how the immune system learns tolerance during infancy.
Gary Falcetano (12:48):
Yeah, because I mean patients often ask, "Well, what probiotic should I take now that I have a food allergy?" But that's really not the question we should be asking. I think what science is saying now is what happened years before that allergy even ever developed?
Luke Lemons (13:05):
And one of the biggest discoveries over the last decade is that children who eventually develop food allergies often have different gut microbial communities within the first months of life compared to children who successfully develop a food tolerance.
Gary Falcetano (13:20):
Right. And that doesn't necessarily mean those microbes cause the allergy. We know correlation doesn't mean causation, but that association has been remarkably consistent across multiple birth cohort studies.
Luke Lemons (13:32):
And that's one of the reasons that food allergy has become one of the most active areas in microbiome research. It's really fascinating.
Gary Falcetano (13:39):
It is, because I think it's a big conceptual change that really over the last 10 years moving from identifying good or bad bacteria to really looking at those metabolites, what do the bacteria produce? And then what do those metabolically active substances, how do they actually turn on or turn off immune responses in the body?
Luke Lemons (14:01):
They're not just sitting there in the intestines. Like you're saying, they're making things in molecules that communicate with the greater organism of us. And so why don't we start with butyrate?
Gary Falcetano (14:13):
Butyrate. All right, I've got your fun fact for the day, Luke,
Luke Lemons (14:17):
Before we
Gary Falcetano (14:17):
Go into what butyrate is. Butyrate, B-U-T, right? Y-R-A-T-E, butyrate starts with BUT just like butter does. So butter does actually contain of the foods that we consume the most high levels of butyrate. That said, that's not where we get most of our butyrate from, hopefully. I don't know. Maybe some of us do, right?
Luke Lemons (14:41):
Yeah, we'll have to have a conversation about my health. If you see me one day eating a stick of butter. And so butyrate is one of the several short-chain fatty acids produced when gut bacteria ferment dietary fiber. These metabolites appear to support several things that are incredibly important for allergy prevention. So they help maintain the intestinal epithelial barrier, and they also promote the development of regulatory T cells. And that right there should be like an alarm going off when we think about allergy.
Gary Falcetano (15:09):
Those regulatory T cells really help to keep the immune system in balance. They suppress or dampen Th2 responses, which we know those Th2 responses and that class switching from a Th1 predominant to a Th2 predominant response is really what's responsible for allergic disease.
Luke Lemons (15:29):
Yeah, it's helping the body or the immune system understand that this peanut isn't dangerous. This egg isn't dangerous. This milk protein isn't dangerous. So when we think about the development of allergies and the immune system, it's not how does the immune system attack, but how does it learn not to attack?
Gary Falcetano (15:47):
And some of it is preventative. So setting up the immune system so that it doesn't respond with an allergic response, but some of it also is later tolerance. And that's kind of the concept of immunotherapy where we do kind of class switching back from a Th2 to a Th1 response. And that's where we see things like IgG and IgG4 being protective.
Luke Lemons (16:10):
Yeah. So Gary, what should primary care clinicians actually do with this information?
Gary Falcetano (16:15):
Yeah. So I mean going back to butyrate, going back to having diverse diets, having healthy plant-forward diets, butyrate is produced from those typically plant type foods with high digestible fibers. So it's a matter of not getting too focused on necessarily one type of diet or another, but really having a more diverse diet. That is typically kind of what's understood now to be generally healthy for our overall health, not just for prevention of allergy.
Luke Lemons (16:49):
Yeah, but when we do think about allergy, we have to remember that the microbiome doesn't really change how we diagnose food allergy. It helps explain why these allergies may develop. But when you're evaluating a child with a suspected food allergy, you still have to be asking those same questions, right?
Gary Falcetano (17:07):
Absolutely. So when we're taking a food allergy history, we want to know what happened, what foods were being consumed, what is their relationship to when and how they were consumed and when symptoms developed? How quickly did the symptoms occur? And do they occur every time under same or similar circumstances? And then what does that history tell us that can lead us now to moving the diagnosis forward, potentially ordering allergy diagnostic testing, specific IgE blood testing? And obviously then once we get those results, we have to correlate them. We correlate them with the history and that's how we make a diagnosis.
Luke Lemons (17:46):
And I want to talk about that specific IgE blood testing because after we've gone through clinical history and we've determined that this may be an IgE-mediated reaction, there are certain specific IgE tests that also use allergen components to help get a more in-depth picture. It looks at proteins across different types of food allergens. And that can also be extremely helpful when making a referral to whether a food challenge would be safe or even just building a management plan.
Gary Falcetano (18:14):
Yeah. So let me unpack that for a second, Luke. We know that whole allergen testing is very, very sensitive. So it has a very high negative predictive value. When we get a negative result when we've tested for a whole allergen that we're suspecting, that's very reassuring that that's not what's causing symptoms. When we get a positive result, you have to go back to that history, try to correlate it to make the diagnosis. And a lot of times that's difficult. Where the allergen components come in is they add specificity. So they allow us to really look at what in that whole allergen patients are reacting to. And sometimes those are less risky proteins and allergen components, and sometimes they're more risky. And that, as you said, helps us then develop kind of a management plan. Does this patient need a referral because they're at low risk for a reaction and maybe they need a food challenge with an allergy specialist?
Luke Lemons (19:54):
Exactly. And so all that is so important when a patient does come in who is showing symptoms of already having a food allergy. But let's rewind a little bit to before those symptoms even appear. And one of the biggest advances in allergy prevention over the past decade has been moving away from delaying those allergenic foods. We now know that introducing peanut-containing foods during infancy in appropriate patients actually reduces the likelihood of developing a peanut allergy.
Gary Falcetano (20:24):
Yeah, there was a landmark trial, and we've discussed this, we've discussed it with Ruchi Gupta when she was on the podcast, but there was a landmark trial that really demonstrated that, especially for children at high risk, so those with moderate to severe eczema, egg allergy, really early on, they had the best success of preventing future peanut allergy by incorporating peanut into the diet really early. So four to six to seven months old. And what we saw was almost a little over 80% relative reduction of peanut allergy in those patients that had an early introduction to peanut and continued that as opposed to those that avoided peanut up until they were two or three years old.
Luke Lemons (21:07):
And to be clear, when we talk about this early introduction, the LEAP study is what we're talking about, which showed that it wasn't designed as a microbiome study, but it is consistent with this broader idea that early life represents a critical window in immune education. And the microbiome may just be one part of that.
Gary Falcetano (21:28):
It very well may. And it is about training that immune system early to recognize things as not harmful, to tolerate those vast array of things we encounter as being kind of normal substances and not harmful substances.
Luke Lemons (21:45):
So food allergy probably has the strongest microbiome story like we mentioned earlier, but it's not the only allergic disease that researchers are studying. Why don't we move from the gut to the skin? Because eczema, atopic dermatitis turns out to have its own fascinating microbiome story.
Gary Falcetano (22:06):
It does. So remember back to our atopic dermatitis episode, we talked about the old style thinking of atopic dermatitis and eczema was that it was a skin condition caused by allergy. And then we learned in that episode that it really is a barrier dysfunction that can precipitate allergy, but there's even more to the story than that. There's a connection between what happens in our gut and what actually happens on our skin.
Gary Falcetano (22:50):
Yeah. So the gut and skin may seem like they're on really opposite ends of the body. But immunologically, they're really constantly communicating. The gut microbiome produces metabolites that circulate throughout the body. And these metabolites, some of them at least, influence immune regulation. So for instance, pro-inflammatory cytokines like tumor necrosis factor alpha, interleukin-1 beta, they all are pro-inflammation. And that inflammation then feeds into that epithelial barrier function.
Luke Lemons (23:20):
And this is why we call it the gut-skin axis, because we know the gut digests foods into important nutrients and chemicals that circulate the whole body. It only makes sense that the microbiome existing inside of the gut can influence the greater biological system like skin, depending on what chemicals or metabolites they're producing.
Gary Falcetano (23:43):
Right. And that's not the only microbiome that comes into play when we're talking about atopic dermatitis or eczema. We have the skin microbiome as well. In fact, patients with atopic dermatitis often have less microbial diversity on their skin than patients with normal or intact skin.
Luke Lemons (24:00):
And instead of a balanced community of microorganisms on their skin, there's one bacteria that often begins to dominate.
Gary Falcetano (24:09):
Yeah. We've seen staph aureus in numerous studies. The colonization of staph aureus increases dramatically during eczema flares.
Luke Lemons (24:19):
And so it actively contributes to this inflammation. It produces toxins, enterotoxins that stimulate the immune system, and it further disrupts the skin barrier. And that's why eczema can be so difficult to control sometimes.
Gary Falcetano (24:33):
Yes. So I think there's still quite a debate on what comes first. Does the eczema cause the microbiome to change? Does the microbiome affect and cause the eczema to either develop or become worse? I think probably the answer is both. And
Luke Lemons (24:49):
When we say both, that's why we say that eczema can be such a vicious cycle because it might be that there's multiple factors contributing to this inflammation. But when we think of a clinical takeaway with the microbiome and its relation to atopic dermatitis, how does that change the ways that primary care clinicians manage eczema?
Gary Falcetano (25:11):
So it brings us back to probably the most important thing is good skincare. Regular moisturization, regular hydration of the skin. Early on, before we even start to see atopic dermatitis or eczema even develop, making sure that their skin is protected throughout infancy is so important.
Luke Lemons (25:31):
Yeah, because the microbiome helps us explain eczema, but it doesn't replace evidence-based management. And you had mentioned moisturization in children or patients who are showing symptoms. I think it's especially important to inform parents of these patients that when they're moisturizing their child's skin, it's important that they wash their hands beforehand too. We often think about washing your hands after. You do
Gary Falcetano (25:55):
The diaper change, right? Yeah. You're going to wash your hands after. But I think it's just as important. We think about in the hospital, we scrub in, scrub out of rooms. You always wash your hands before you see a patient and after. Same thing with infants. Think about this, Luke. Especially if you have a child that is starting to have non-intact skin and you're moisturizing, you're doing a good job to really help treat that eczema. You eat a can of mixed nuts and then go change the baby's diaper, moisturize, and then wash your hands. You've just introduced those nut allergens directly through the non-intact skin.
Luke Lemons (26:32):
And the moisturization can more or less lock in those outside particles or molecules. And so yeah, that's a good takeaway to any primary clinicians out there who are helping inform early parents about eczema and their children to scrub in, scrub out.
Gary Falcetano (26:48):
We talked about that in our previous episode, but it really is important, right? Because we know that if you don't get that early introduction of foods through the gut to promote tolerance, if their first exposure to these food antigens and allergens is through a non-intact skin, that's where we get increasing prevalence of food allergy. And that's why there's such a connection between, we talk about the atopic march. Non-intact skin causing development of or leading to development of food allergy, leading to rhinitis, leading to asthma. That whole progress, trying to interrupt that by taking really good care of that skin can really affect the patient or the child downstream.
Luke Lemons (28:14):
So if a patient comes into the clinic tomorrow and they ask, "Should I buy this probiotic because my child has eczema?" Well, the evidence isn't strong enough to routinely recommend that. There's some promising studies and there's a few strains that show potential, but the results have been inconsistent. And this is a takeaway here with eczema and the microbiome. It's that no major allergy guideline currently recommends routine probiotic therapy as a standard eczema treatment.
Gary Falcetano (28:41):
Yeah. As we mentioned on the previous episode, things like topical steroids, from moderate to severe eczema, we get into biologics. There's a lot of conventional medical treatments out there, and we need to base our treatments on that. There's just not the evidence there of altering the microbiome at this point.
Luke Lemons (29:00):
And going back to the allergic march that you had outlined earlier, Gary, which is it starts with eczema and then to food allergy and then to either asthma or allergic rhinitis. It's not always the same march for a patient, but why don't we talk a little bit about the latter half of that march, the asthma and the allergic rhinitis and their relation to the microbiome?
Gary Falcetano (29:27):
Yeah. So again, I think this is an area where there's not a lot of conclusive evidence. There's a lot of research going on. But what we do know plays a role currently in not only the development, but the status and the severity of asthma is things like genetics, certainly. Viral infections early in life, air pollution, and where you live in a city can be a big difference as to whether you develop and how severe your asthma symptoms are. Even socioeconomic factors, And especially, how many times have we talked about this? Environmental allergen exposures. We know 60% of adults, 90% of children have allergic triggers that contribute to their asthma symptoms. So it's so important to assess their allergic triggers and do some of that proactive preventative steps to reduce exposure to their identified allergens.
Luke Lemons (30:23):
So maybe the microbiome isn't the cause of asthma. It's still a part of that asthma's risk architecture, starting with eczema and food allergy. Exactly. I mean, again, this is the march. So asthma, allergic rhinitis are towards the end. But in the beginning, remember, microbiome, this is a conversation of early life. And so things that are happening. And so the way the immune system develops in those early phases can domino effect later down the line.
Luke Lemons (31:24):
And so you may be asking, okay, this is all great, but what actually changes for primary care clinicians in asthma management considering all this information on the microbiome in early development? And the truth is not much about diagnosis.
Gary Falcetano (31:40):
No. So if a child presents with recurrent wheezing, we're still asking the same questions. Are the symptoms triggered or exacerbated by viral infections? Almost always, yes. What about exercise? What about seasonal allergens? We've mentioned in the beginning of this episode, the asthma peak week coming up. That's a tsunami of triggers, both viral triggers being back in a classroom, allergic triggers with ragweed in the fall, indoor triggers like pets, molds, dust mites. And they all combine in the fall to really cause the most asthma exacerbations than we see at any other time of the year.
Luke Lemons (32:18):
And that's why it's important if you do have any patients who have asthma, that they be evaluated for some of their environmental triggers. And you can do that with a specific IgE blood test. They have localized respiratory profiles. Well, if you click the link in the description of this episode, there is a lab ordering guide that has all the test codes for your local environmental respiratory profiles from labs that you use. And just preparing for peak week and making sure that these patients are under control starts with understanding what could be triggering their symptoms and building a management plan.
Gary Falcetano (32:51):
You know what, Luke, I just want to emphasize that. You mentioned respiratory allergen profiles. So often as clinicians, we're kind of overwhelmed with which laboratory test to select for a patient. And I'm trying to assess a patient's allergies. We're thinking, could it be the pollens? Could it be
Luke Lemons (33:08):
Some
Gary Falcetano (33:08):
Indoor allergens? Trying to pick and choose those from a laundry list of potential allergens is usually not that effective. We've talked about in the past, most of us don't have a minor in botany. We don't know which trees, grasses, weeds are necessarily in our area, which ones are potentially cross-reactive so that we don't have to order a bunch that are the same. Those respiratory allergen profiles are really designed by experts to give us the broadest coverage of both those outdoor pollens in a certain geography, but also the really relevant indoor pollens like the dust mites, like the pets, like the molds, like mice, cockroach, all the things that we know have been identified as drivers of allergic disease and asthma.
Luke Lemons (33:52):
It is such a helpful tool. And the microbiome, knowing all of this about its relation to eczema, food allergy in asthma, it doesn't replace any of that. It simply helps us understand why, for example, some children may develop asthma in the first place, but it's those tools like those respiratory profiles that really help us manage these patients. And the same can also be said for allergic rhinitis. And why don't we jump over there in its relation to the microbiome?
Gary Falcetano (34:20):
Yeah. So I mean, all of our surfaces, whether it be our lower airways, our upper airways, the nasal microbiome, they all obviously contain these trillions of microbes that interact with us. Where I want to bring this back to, Luke, is actually how we can negatively affect that biome. And we know that over-prescribing of antibiotics can certainly negatively affect the biome and change the proportion of beneficial versus pathogenic bacteria in that biome. So while antibiotics are really important, it's important to have great antibiotic stewardship. And part of that is not treating allergic disease as suspected bacterial disease and using antibiotics when they're not indicated. And I think that's where looking at rhinitis, looking at allergic asthma, making that diagnosis so that the patient with chronic sinus infections every fall, maybe that isn't a bacterial overgrowth, right? Maybe that's actually allergic disease and we need to diagnose that properly.
Luke Lemons (35:24):
I love that point because as we're talking about the microbiome and allergies, if we're just prescribing antibiotics, it could be affecting that microbiome early in development. There's studies that have consistently found associations between early life antibiotic exposure and increased risks of asthma, eczema, and allergic diseases. I want to say also that this is an association, which doesn't necessarily mean causation. I don't want anybody listening to think that what we're saying is antibiotics cause allergies because there are patients out there who may ask you and say, "Hey, are these antibiotics going to cause my child to develop an allergy?" And there's association, but this is confounding by indication.
Gary Falcetano (36:09):
Well, yeah, because if you're getting antibiotics in early life, especially for a severe respiratory infection, those infections themselves have been associated with later development of recurrent wheezing or asthma. So we don't know what's actually the causative thing here, but we still come back to appropriate antibiotic use is important no matter what.
Luke Lemons (36:32):
So let's recap where we are here. The microbiome probably has its strongest evidence in food allergy. The evidence is also compelling for eczema, but for asthma and allergic rhinitis, it remains a little more associative. It hasn't yet changed clinical practice and the microbiome instead has transformed how we think about allergic diseases, but it hasn't transformed how we diagnose. We've talked about all the different ways that we still have to go through the standard procedure of diagnosing food allergy, eczema, asthma, allergic rhinitis. So Gary, I'm curious, what are your biggest takeaways that every clinician should know about the microbiome and allergy?
Gary Falcetano (37:15):
I think you've said it, but to kind of reiterate, right? The microbiome does matter. It's an important part of immune development, especially during early life. And that coincides with what we're learning now about early allergen introduction and how important it is to training the immune system. So that's number one. I think number two, as you said, food allergy really is an area where the strongest evidence exists for a healthy functional microbiome. What that looks like, how we can actually achieve that is something that the evidence is still in development, right? But it's important to have as diverse as possible diet. And that's regardless of the microbiome, but it's certainly we know now it really contributes to a very healthy biome.
Luke Lemons (38:06):
I just want to jump in here on that second point. That diversity of diet early in life is extremely important. And it also relates to how important it is to understand exactly what a patient may be allergic to when it comes to food early in life. If you do testing with allergen components and are able to identify that this child can tolerate baked milk, or maybe they're allergic to a less severe protein and peanut that allows them to introduce peanut into the diet, these findings are incredibly important in adding to that diversity of food.
Gary Falcetano (38:42):
So I'm going to beat the dead horse here. Getting to the right diagnosis is the most important thing. I think clinicians are guilty of this, parents are guilty, patients when they're older are guilty of this. We have an adverse reaction to a food. We think we know what happened. We call it an allergy. We avoid that food. Parents rightly are very anxious about potential food allergies, getting to the right diagnosis through the proper structured food allergy evaluation, through a proper food allergy history, targeted testing, use of allergen components to provide clarity. All of that is how we get to a clear diagnosis of either allergic or not. And when we're not, we can increase that diet diversity, helping not only their wellbeing overall, but their microbial wellbeing too.
Luke Lemons (39:33):
Love that. So sorry to hijack your biggest takeaways, Gary. So no, to recap, number two is that there's a strong link between food allergy and the microbiome. What's your number three takeaway? I
Gary Falcetano (39:43):
Would say that while the microbiome likely contributes to eczema and in some associative way, asthma and allergic rhinitis too, there's really no solid evidence that we can bring into clinical practice to really change that. And then what about number four, Luke? What do you think? What's the number four
Luke Lemons (40:00):
Takeaway
Gary Falcetano (40:00):
Here?
Luke Lemons (40:00):
Well, I think that the biggest takeaway for any clinicians listening out there is that the microbiome helps explain why allergic diseases develop. Yeah, helps.
Gary Falcetano (40:11):
It
Luke Lemons (40:11):
Doesn't completely explain it, but it helps. So I think that the biggest takeaway to our clinician audience is that the microbiome helps explain why allergic diseases may develop.
(40:26):
It doesn't replace evidence-based diagnosis or treatment. It's explaining the why. The microbiome has given us a much better understanding of allergy, but when a patient is sitting in front of you, you're still trying to answer those same clinical questions. Is this actually an allergy? And if so, what's causing it? And one of the things that can help you with answering those questions is utilizing specific IgE blood testing as part of that diagnosis pathway. And if you check the description of this episode, you'll find a link and that will take you to the webpage for this episode, which will have a lab ordering guide for all the labs that you may use and localized respiratory profile test codes as well that we had mentioned earlier.
Gary Falcetano (41:11):
Yeah. Getting to the right diagnosis is so important for general wellbeing, microbial wellbeing. I want to thank you for taking the time to listen, and we'll see you next time.
ImmunoCAST Voice (41:28):
Immunocast is brought to you by Thermo Fisher Scientific, creators of ImmunoCAP specific IgE diagnostics and Phadia laboratory systems. For more information on allergies and specific IgE testing, please visit thermofisher dot com slash immunocast. Specific IgE testing is an aid to healthcare providers in the diagnosis of allergy and cannot alone diagnose a clinical allergy. Clinical history alongside specific IgE testing is needed to diagnose a clinical allergy. The content of this podcast is not intended to be and should not be interpreted as or substitute professional medical advice, diagnosis, or treatment. Any medical questions pertaining to one's own health should be discussed with a healthcare provider. This podcast was edited by Resonate Recordings.
Before you proceed ...
We noticed you may be visiting a version of our website that doesn’t match your current location. Would you like to view content based on your region?
Talk with us
Interested in utilizing our solutions in your laboratory or healthcare practice?
This form is dedicated to healthcare and laboratory professionals who work within medical laboratories, private practices, health systems, and the like.
By clicking "continue with form" you are confirming that you work within a healthcare or laboratory space.
Not a lab professional or clinician but interested in diagnostic testing for allergies?
Visit Allergy InsiderChoose your preferred language
Please note: By selecting a different language, you are choosing to view another site. Product availability and indications may vary from what is approved in your region.